These findings are consistent with those of Abe et al. [34], who reported that NT-proBNP was associated with both myeloma-related renal dysfunction and left ventricular diastolic dysfunction—highlighting NT-proBNP’s potential as a composite marker for both cardiac and renal impairment in MM. The gene discussed is NPPB; the disease is plasma cell myeloma.